(VIANEWS) – PANORO ENERGY (PEN.OL), GJENSIDIGE FORSIKR (GJF.OL), ELIS (ELIS.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. PANORO ENERGY (PEN.OL)
136.7% sales growth and 9.27% return on equity
Panoro Energy ASA, an independent exploration and production company, engages in the exploration, development, and production of oil and gas properties in Africa. It holds assets in the Equatorial Guinea, Gabon, Tunisia, and South Africa. The company was incorporated in 2009 and is based in London, the United Kingdom.
Earnings Per Share
As for profitability, PANORO ENERGY has a trailing twelve months EPS of kr1.66.
PE Ratio
PANORO ENERGY has a trailing twelve months price to earnings ratio of 16.22. Meaning, the purchaser of the share is investing kr16.22 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.27%.
Sales Growth
PANORO ENERGY’s sales growth is 272.7% for the present quarter and 136.7% for the next.
Yearly Top and Bottom Value
PANORO ENERGY’s stock is valued at kr26.92 at 22:20 EST, way under its 52-week high of kr36.20 and way above its 52-week low of kr24.08.
Moving Average
PANORO ENERGY’s value is under its 50-day moving average of kr27.85 and below its 200-day moving average of kr29.36.
Revenue Growth
Year-on-year quarterly revenue growth declined by 12.6%, now sitting on 180.27M for the twelve trailing months.
More news about PANORO ENERGY.
2. GJENSIDIGE FORSIKR (GJF.OL)
83.1% sales growth and 21.65% return on equity
Gjensidige Forsikring ASA provides general insurance and pension products in Norway, Sweden, Denmark, Latvia, Lithuania, and Estonia. The company operates through six segments: General Insurance Private, General Insurance Commercial, General Insurance Denmark, General Insurance Sweden, General Insurance Baltics, and Pension. It offers motor, accident and health, travel, leisure craft, valuables, liability, commercial, marine/transport, agriculture, natural perils, life, and pet insurance products. The company also provides defined contribution occupational pension schemes for businesses, which include disability pension, spouse/cohabitant pension, and child's pension products. It distributes its products through various distribution channels comprising office channel, call center, Internet, partners, and brokers to private and commercial customers. The company was founded in 1816 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, GJENSIDIGE FORSIKR has a trailing twelve months EPS of kr9.33.
PE Ratio
GJENSIDIGE FORSIKR has a trailing twelve months price to earnings ratio of 19.4. Meaning, the purchaser of the share is investing kr19.4 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 21.65%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
GJENSIDIGE FORSIKR’s EBITDA is 2.63.
Sales Growth
GJENSIDIGE FORSIKR’s sales growth for the next quarter is 83.1%.
More news about GJENSIDIGE FORSIKR.
3. ELIS (ELIS.PA)
77.2% sales growth and 6.57% return on equity
Elis SA provides flat linen, workwear, and hygiene and well-being solutions in France, Central Europe, Scandinavia, Eastern Europe, the United Kingdom, Ireland, Latin America, Southern Europe, and internationally. The company offers table, bed, kitchen, patient, and bath linens; workwear and personal protective equipment; beverage solutions, such as water coolers and accessories, cups and bottles, and coffee machines; floor protection mats and mops; industrial wipers; and pest and rodent control, insect control, or disinfection services. It also provides washroom hygiene services, such as hand washing and drying, toilet hygiene and urinals, lavatories, and air fragrancing; and reusable cleanroom garments, footwear, goggles, and related contamination control solutions, as well as cleaning systems. In addition, the company offers various solutions for collection and disposal of infectious waste, as well as laundry facilities. It primarily serves the catering, accommodation, healthcare and social welfare, industries, trade and retail, and services sectors, as well as public authorities and administration. Elis SA was founded in 1883 and is headquartered in Saint-Cloud, France.
Earnings Per Share
As for profitability, ELIS has a trailing twelve months EPS of €0.85.
PE Ratio
ELIS has a trailing twelve months price to earnings ratio of 20.4. Meaning, the purchaser of the share is investing €20.4 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 6.57%.
Sales Growth
ELIS’s sales growth for the next quarter is 77.2%.
Moving Average
ELIS’s worth is above its 50-day moving average of €17.25 and way higher than its 200-day moving average of €14.28.
More news about ELIS.
4. TOTENS SPAREBANK (TOTG.OL)
22.5% sales growth and 10.47% return on equity
Totens Sparebank provides various banking and financial products and services in Norway. The company offers savings and pension products; business and construction loans; leasing; overdrafts and bank guarantees; liability, business, data attack, property damage, craftsman, health, homeowners, collective, personnel, travel, occupational injury, agriculture, and vehicle insurance; and business and credit cards. It also provides online and mobile banking services; payment solutions; asset management; and real estate services. Totens Sparebank was founded in 1854 and is headquartered in Lena, Norway.
Earnings Per Share
As for profitability, TOTENS SPAREBANK has a trailing twelve months EPS of kr20.53.
PE Ratio
TOTENS SPAREBANK has a trailing twelve months price to earnings ratio of 9.64. Meaning, the purchaser of the share is investing kr9.64 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.47%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 12.8%, now sitting on 503.35M for the twelve trailing months.
More news about TOTENS SPAREBANK.
5. MEDISTIM (MEDI.OL)
16.7% sales growth and 31.89% return on equity
Medistim ASA develops, produces, services, leases, and distributes medical devices for cardio-vascular surgery in the United States, Europe, Asia, and internationally. It offers MiraQ Cardiac, a system that combines ultrasound imaging and transit time flow measurement (TTFM) in a single system for cardiac surgery; MiraQ Vascular, a system that combines ultrasound imaging and transit TTFM in a single system for vascular surgery; and imaging probes for intraoperative use. The company also provides various flow probes, such as QuickFit TTFM probes to accurately measure blood volume flow intraoperatively in various range of surgical applications; Vascular TTFM probes for enhancing surgical outcomes; and doppler probes that are used on the surface of the heart/vessel to search for intramural coronary arteries or to locate the position and quantify the degree of a stenosis. In addition, it distributes and sells third party medical equipment. The company was incorporated in 1984 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MEDISTIM has a trailing twelve months EPS of kr6.62.
PE Ratio
MEDISTIM has a trailing twelve months price to earnings ratio of 42.45. Meaning, the purchaser of the share is investing kr42.45 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.89%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MEDISTIM’s EBITDA is 8.9.
Sales Growth
MEDISTIM’s sales growth is 15.7% for the ongoing quarter and 16.7% for the next.
Growth Estimates Quarters
The company’s growth estimates for the present quarter is a negative 17.7% and positive 11.1% for the next.
Yearly Top and Bottom Value
MEDISTIM’s stock is valued at kr281.00 at 22:20 EST, way below its 52-week high of kr330.00 and way above its 52-week low of kr184.80.
More news about MEDISTIM.
6. MOWI (MOWI.OL)
13.9% sales growth and 23.04% return on equity
Mowi ASA, a seafood company, produces and supplies farmed salmon products worldwide. It operates through three segments: Feed, Farming, and Sales and Marketing. The company is involved in the salmon feed production, salmon farming and primary processing, and seafood secondary processing activities. It offers whole gutted fish, including Label Rouge and organic salmon; and white fish and other seafood products, as well as fillets, steaks, cutlets, portions, loins, kebabs, and steak combos. The company also provides value added products, such as breaded, pre-fried, dusted, marinated, grilled, battered, topped, filled with sauce, delicatessen, fresh fish ready meal, and smoked fish products. It offers its products under the Mowi, Mowi Salmon, Donegal Silver, Admiral's, Pieters, Laschinger, Kritsen, Ducktrap River, Harbour Salmon Co., Rebel Fish, Supreme Salmon, Olav's, Northern Harvest, and Mowi Nutrition brand names. The company was formerly known as Marine Harvest ASA and changed its name to Mowi ASA in December 2018. Mowi ASA was founded in 1964 and is headquartered in Bergen, Norway.
Earnings Per Share
As for profitability, MOWI has a trailing twelve months EPS of kr17.6.
PE Ratio
MOWI has a trailing twelve months price to earnings ratio of 10.82. Meaning, the purchaser of the share is investing kr10.82 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.04%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 18.4%, now sitting on 4.94B for the twelve trailing months.
Sales Growth
MOWI’s sales growth is 18.1% for the current quarter and 13.9% for the next.
More news about MOWI.
